|
PGM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.412800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.738800E-01 |
| Normal-vs-Stage2 |
8.662200E-01 |
| Normal-vs-Stage3 |
2.578600E-01 |
| Normal-vs-Stage4 |
4.536400E-01 |
| Stage1-vs-Stage2 |
6.850000E-01 |
| Stage1-vs-Stage3 |
7.984000E-01 |
| Stage1-vs-Stage4 |
9.774600E-01 |
| Stage2-vs-Stage3 |
6.068400E-01 |
| Stage2-vs-Stage4 |
7.148800E-01 |
| Stage3-vs-Stage4 |
8.821800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.418000E-01 |
| Normal-vs-AfricanAmerican |
1.135430E-01 |
| Normal-vs-Asian |
2.880800E-01 |
| Caucasian-vs-AfricanAmerican |
2.390200E-01 |
| Caucasian-vs-Asian |
5.885000E-01 |
| AfricanAmerican-vs-Asian |
6.015800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.691400E-01 |
| Normal-vs-Female |
1.552430E-01 |
| Male-vs-Female |
2.940000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.678400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.030980E-01 |
| Normal-vs-Age(61-80Yrs) |
2.190000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.522800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.915380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.446200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.121800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.059800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.987800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.588000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.770600E-01 |
| Classical-VS-Follicular |
8.801200E-04 |
| Classical-VS-Other |
9.572000E-01 |
| Classical-VS-Normal |
8.627000E-01 |
| Tall-VS-Follicular |
2.646400E-02 |
| Tall-VS-Other |
9.014800E-01 |
| Tall-VS-Normal |
8.508400E-01 |
| Follicular-VS-Other |
6.187800E-01 |
| Follicular-VS-Normal |
3.937200E-03 |
| Other-VS-Normal |
9.361000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.802000E-02 |
| Normal-vs-N1 |
1.369380E-01 |
| N0-vs-N1 |
8.882600E-01 |
|
|
